However, in the recent study, within the GPA group (N = 151, 29% MPO+) patients with MPO-ANCA were older, and characterized by less prevalent ENT and neurological manifestations, increased end-stage renal disease (ESRD) and mortality (139). Here, MPO is linked to stage 5 chronic kidney disease.